Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 241–248 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Alector Inc. AL001 Amyotrophic lateral sclerosis (ALS) Phase 2 Ongoing oral Neurology
Alector Inc. AL101/GSK4527226 - (PROGRESS-AD) Early Alzheimer's disease (AD) Phase 2 Ongoing Oral Neurology
Alector Inc. AL002 - (INVOKE-2) Alzheimer’s disease Phase 2 Data Released Intravenous Neurology
Alector Inc. Latozinemab (AL001) - (INFRONT-3) Frontotemporal Dementia Phase 3 Trial Discontinued intravenous Neurology
Alector Inc. AL001 - (INFRONT-2) Frontotemporal Dementia Phase 2 Ongoing Intravenous Neurology
Alector Inc. Latozinemab (AL001) - (INFRONT-3) Frontotemporal Dementia Phase 3 Trial Discontinued intravenous Neurology
Aligos Therapeutics Inc. Pevifoscorvir (ALG-000184) - (B-SUPREME) Chronic HBV Infection Phase 2 Enrollment Initiation Oral Antiviral
Aligos Therapeutics Inc. ALG-055009 - (HERALD) Metabolic dysfunction-associated steatohepatitis (MASH) Phase 2a Data Released Oral Gastroenterology